Cognitive FunctioningNCT07747181
The Effect of Combined Brain Stimulation and Yoga for Improving Cognitive Function in Psychosis
A study testing Active tDCS and Yoga in people with Cognitive Functioning and Psychosis, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
Trial summary
The study examines (1) the effects of active anodal (facilitatory) tDCS and yoga combined intervention on cognitive function, clinical symptoms, and quality of life domains (social function and physical wellbeing) in psychosis, and (2) the neurophysiological mechanisms underlying the effects induced by the combined… Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Cognitive Functioning, Psychosis
- What is being tested?
- Active tDCS and Yoga
- Type of treatment
- Medical device, Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 135 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Jan 2026to 30 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- (1) aged 18 to 65 years
- (2) diagnosis based on SCID for schizophrenia and related disorders, psychosis, and delusional disorder with the positive symptom measured by CGI ≤ 3
- (3) ability to understand the nature of the study and to give informed consent (The MacArthur Competence Assessment Tool for Clinical Research score ≥ 35)
- (4) Chinese-speaking
- (5) fewer than 10 hours of yoga and other mind-body intervention (e.g., Tai Chi, Qigong, Mindfulness) in the previous 3 months.
Who cannot join
- (1) Severe physical diseases, such as myocardial infarction, uncontrollable severe hypertension, fracture, severe spinal problems, or contraindication for exercise
- (2) comorbid substance dependence and seizure disorders
- (3) pregnancy or other contraindication to fNIRS
- (4) known history of intellectual disability or special school attendance, brain trauma, or organic brain disease
- (5) Individuals taking Benzodiazepine will still be recruited in the project, and will be excluded from the fNIRS measure.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
The Hong Kong Polytechnic University
Hung Hom, Kowloon
Prof. Jessie LIN, +85227666718, jx-jessie.lin@polyu.edu.hk
About this study
Official title: Yoga and tDCS to Improve Cognitive Function in Individuals With Psychosis: A Pragmatic Controlled Trial
The study examines (1) the effects of active anodal (facilitatory) tDCS and yoga combined intervention on cognitive function, clinical symptoms, and quality of life domains (social function and physical wellbeing) in psychosis, and (2) the neurophysiological mechanisms underlying the effects induced by the combined intervention.
- Conditions
- Cognitive Functioning, Psychosis
- Being tested
- Active tDCS, Sham tDCS, Yoga
- Medical subject headings
- Psychotic Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Active tDCSDevice
Active tDCS will be applied using a wearable stimulator (LifTid) with a constant stimulation intensity of 1.2 mA for 20 minutes. The device has been designed for anodal stimulation targeting DLPFC using the F3 (anode) to F4 (cathode) montage.
Sham tDCSDevice
Sham tDCS will be performed using the same device but without stimulation. During the yoga training, all participants will wear the device and a facilitator will turn on the stimulation for participants receiving a-tDCS-Y intervention, and pretend to turn on the stimulation for participants receiving s-tDCS-Y intervention after the first 10-minute section.
YogaBehavioural
Yoga will be based on the basic theory and research of the foundation of Hatha yoga. Participants will cultivate the learning of yoga through various kinds of activity, such as breathing control, body postures, and relaxation. The yoga is designed to create an overall effect on the body and mind through strength training and stretching with a mindful sensation. Each 1-hour intervention session contains reviewing the last week self-practice, breathing practice and warm-up (10 minutes), posture sequences (40 minutes), relaxation (5 minutes), reflection and feedback (5 minutes). Video clips will be provided through social media apps (i.e., WhatsApp, WeChat) to enable home-based practice at least twice weekly. A logbook will be distributed to the participants for their record of self-practice and will be reviewed weekly by the intervention facilitator.
| Study group | Role | What they receive |
|---|---|---|
| Active tDCS and yoga | Active comparator | Not described Receives: Device: Active tDCS; Behavioral: Yoga |
| Sham tDCS and yoga | Sham comparator | Not described Receives: Device: Sham tDCS; Behavioral: Yoga |
| Waitlist control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Verbal Fluency Test
A measure of executive function. Participants have to name as many animals as possible in 60 seconds. Higher scores indicate better executive functioning.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Secondary outcomes (17)
Logical Memory test
The Logical Memory test is a standardized test used to evaluate narrative verbal memory, immediate free recall, and delayed free recall. The examiner reads one short, structured stories aloud to the participant. The test consists of two main parts: Logical Memory I (Immediate Recall), where the participant is asked to retell the story from memory immediately after hearing it, and Logical Memory II (Delayed Recall), where the participant is asked to retell the story again after a 30-minute delay. Scoring is based on the total number of predefined story elements or ideas correctly recalled. For each story, the raw score ranges from 0 to 23 story units. Higher scores indicate better verbal memory and auditory narrative recall capabilities.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Digit Span Test
The Digit Span Test is a standardized cognitive subtest used to evaluate short-term verbal memory, attention, and working memory. The examiner reads a sequence of random numbers aloud at a rate of one digit per second, and the participant is asked to repeat them. The test consists of two primary components: Digit Span Forward (where digits are repeated in the exact order heard to assess attention and short-term memory) and Digit Span Backward (where digits are repeated in the reverse order to assess working memory and mental manipulation). Scoring is based on the total number of trials correctly recalled. Higher scores indicate better auditory attention, short-term memory capacity, and working memory functioning.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Positive and Negative Syndrome Scale (PANSS)
The Positive and Negative Syndrome Scale (PANSS) is a 30-item rating scale used to measure the symptom severity of patients with schizophrenia. It consists of three subscales: the Positive Scale (7 items), the Negative Scale (7 items), and the General Psychopathology Scale (16 items). Each item is rated on a 7-point symptom-severity scale from 1 (absent) to 7 (extreme). The total score ranges from a minimum of 30 to a maximum of 210. Higher scores indicate greater severity of psychiatric symptoms.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Calgary Depression Scale
The Calgary Depression Scale is a 9-item structured interview scale specifically designed to assess the severity of depression in patients with schizophrenia. Each of the 9 items is scored on a 4-point scale from 0 (absent) to 3 (severe). The total score ranges from a minimum of 0 to a maximum of 27. Higher scores indicate more severe depressive symptoms.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Social and Occupational Functioning Assessment Scale (SOFAS)
The Social and Occupational Functioning Assessment Scale (SOFAS) is a clinician-rated numeric scale used to assess an individual's level of social and occupational functioning, distinct from the severity of their psychological or psychiatric symptoms. The scale ratings range from 1 to 100, divided into 10-point intervals. A score of 100 represents superior functioning in a wide range of activities, while a score of 1 indicates a persistent inability to maintain minimal personal hygiene or gross impairment in social and occupational functioning. Higher scores indicate a higher level of social and occupational functioning and greater independence.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Role Functioning Scale (RFS)
The Role Functioning Scale (RFS) is a 4-item instrument designed to assess the level of functioning of individuals with severe mental illness in four areas: Working Productivity, Immediate Past Social Network, Extended Social Network, and Independent Living / Self-Care. Each of the 4 domains is rated on a 7-point behavioral index scale ranging from 1 (severely impaired) to 7 (optimal functioning). The total score ranges from a minimum of 4 to a maximum of 28. Higher scores indicate a higher level of role functioning and greater independence.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
The Short Form Health Survey (SF-36)
The 36-Item Short Form Health Survey (SF-36) is a patient-reported questionnaire used to assess health-related quality of life. It measures eight health domains: Physical Functioning, Role Limitations due to Physical Health, Role Limitations due to Emotional Problems, Energy/Fatigue, Emotional Well-Being, Social Functioning, Pain, and General Health. Responses are multi-choice, and individual domain scores are transformed onto a scale from 0 to 100. For each domain and summary score, the scale range is 0 to 100, where higher scores indicate better health status and higher quality of life.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
BMI
Body Mass Index (BMI) is a standardized anthropometric measure used to estimate body fat and classify weight status. It is calculated by dividing an individual's body weight in kilograms by the square of their height in meters (kg/m²). Higher BMI values indicate greater body mass relative to height, which can correspond to higher body fat levels.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Sit-and-Reach Test
A common measure of flexibility, specifically assessing the lower back and hamstring muscles. The subject is seated against the wall, arms outstretched towards the box. A sliding ruler is used to measure the position of the fingertips. Higher scores (greater distance reached) indicate greater hamstring and lower back flexibility.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Standing Balance Test
Give the subject a minute to practice their balancing before starting the test. Then ask the person to stand on one foot for as long as possible. The total length of time a person can stay in the balance position will be recorded. The timing stops when the elevated foot touches the ground or the person hops or otherwise loses their balance position. The test will be conducted with the person having their arms on their waist. Repeat the test on the other leg. Higher scores (longer durations) indicate better static balance and postural control.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Digit Symbol Coding Test
The Digit Symbol Coding Test is a standardized paper-and-pencil neurocognitive task used to assess processing speed, attention, psychomotor performance, and visual-motor coordination. Participants are presented with a key pairing single digits (1 through 9) with unique geometric symbols. Below the key, rows of digits are displayed with empty spaces beneath them. Participants are instructed to write the correct corresponding symbol for each digit as quickly and accurately as possible within 120 seconds. The outcome score is calculated as the total number of correct digit-symbol pairs completed within the time frame. Higher scores indicate superior processing speed and enhanced cognitive efficiency.
Measured: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Letter Cancellation Test
The Letter Cancellation Test is a standardized paper-and-pencil psychomotor task used to assess visual attention, sustained attention, psychomotor speed, and visual neglect. Participants are presented with a sheet of paper containing rows of random letters and are instructed to cross out (cancel) a specific target letters as quickly and accurately as possible. The outcome score is reported as the total number of correct targets identified (hits). Higher scores indicate superior visual attention and faster processing speed.
Measured: After the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Trail Making Test (TMT)
The Trail Making Test (TMT) is a standard neurocognitive task used to assess visual search, scanning, processing speed, and executive function. It consists of two distinct parts: Part A and Part B. In Part A (TMT-A), participants are instructed to connect a series of encircled numbers in chronological order (1-2-3, etc.) as quickly and accurately as possible. In Part B (TMT-B), participants must connect a alternating series of encircled numbers and letters in sequential order (1-A-2-B-3-C, etc.). The outcome score for each part is recorded as the total time in seconds required to complete the trail. Lower scores (shorter durations to complete the task) indicate superior processing speed, enhanced cognitive flexibility, and better executive functioning.
Measured: After the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Changes of HbO and HbR in prefrontal regions during resting and cognitive task measured by fNIRS
Functional Near-Infrared Spectroscopy (fNIRS) is a non-invasive optical imaging technique used to monitor hemodynamic responses in the cerebral cortex. This outcome measure evaluates the relative concentration changes of oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HbR) within defined regions of interest in the prefrontal cortex (PFC). Measurements are continuously recorded during two distinct states: a resting-state baseline condition and a target cognitive task condition. Increased HbO concentration accompanied by a concurrent decrease in HbR concentration relative to baseline indicates localized cortical activation in the prefrontal region during the cognitive task.
Measured: Baseline (T0), and after the 6-week interventions/waiting (T1)
Correlation of changes in HbO and HbR among prefrontal regions (connectivity)
Functional connectivity within the prefrontal cortex (PFC) is evaluated by measuring the temporal correlation of hemodynamic signal fluctuations. Continuous fNIRS data for both oxygenated hemoglobin (HbO) and deoxygenated hemoglobin (HbR) are recorded during resting-state and the cognitive task. After preprocessing to remove systemic noise and motion artifacts, the functional connectivity is quantified by calculating the Pearson correlation coefficient (r) and its Fisher z-transformed equivalent between the time courses of different prefrontal regions. The resulting correlation values range from -1.0 to +1.0 . Higher positive values indicate stronger functional connectivity and greater synchronized neural activity between those specific prefrontal cortical regions.
Measured: Baseline (T0), and after the 6-week interventions/waiting (T1)
Attendance of the interventions
Number of class attended during the 6-week intervention.
Measured: After the 6-week interventions/waiting (T1)
Home-based practice frequency and duration checklist
Participants report the frequency and duration of doing the home-based practice.
Measured: After the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2026
- Study start1 Jan 2026
- Primary completion31 Dec 2027 (estimated)
- Study completion30 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cognitive FunctioningStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 135 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The Hong Kong Polytechnic University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, LIN Jingxia Jessie, The Hong Kong Polytechnic University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07747181
- Sponsor's protocol ID
- 25124024
- Status last verified
- Aug 2026
- First submitted
- 30 Jul 2026
- Last updated
- 5 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Yoga and tDCS to Improve Cognitive Function in Individuals With Psychosis: A Pragmatic Controlled Trial
- ClinicalTrials.gov ID
- NCT07747181
- Acronym / sponsor ID
- 25124024
- Conditions
- Cognitive Functioning, Psychosis
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 135 participants (estimated)
- Lead sponsor
- The Hong Kong Polytechnic UniversityUniversity, hospital or other
- Study start
- 1 Jan 2026 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 30 Jun 2028 (estimated)
- First posted
- 5 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study examines (1) the effects of active anodal (facilitatory) tDCS and yoga combined intervention on cognitive function, clinical symptoms, and quality of life domains (social function and physical wellbeing) in psychosis, and (2) the neurophysiological mechanisms underlying the effects induced by the combined intervention.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Active tDCS and yoga | Active comparator | Device: Active tDCS, Behavioral: Yoga |
| Sham tDCS and yoga | Sham comparator | Device: Sham tDCS, Behavioral: Yoga |
| Waitlist control group | No intervention | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- (1) aged 18 to 65 years
- (2) diagnosis based on SCID for schizophrenia and related disorders, psychosis, and delusional disorder with the positive symptom measured by CGI ≤ 3
- (3) ability to understand the nature of the study and to give informed consent (The MacArthur Competence Assessment Tool for Clinical Research score ≥ 35)
- (4) Chinese-speaking
- (5) fewer than 10 hours of yoga and other mind-body intervention (e.g., Tai Chi, Qigong, Mindfulness) in the previous 3 months.
Key exclusion criteria (5 listed)
- (1) Severe physical diseases, such as myocardial infarction, uncontrollable severe hypertension, fracture, severe spinal problems, or contraindication for exercise
- (2) comorbid substance dependence and seizure disorders
- (3) pregnancy or other contraindication to fNIRS
- (4) known history of intellectual disability or special school attendance, brain trauma, or organic brain disease
- (5) Individuals taking Benzodiazepine will still be recruited in the project, and will be excluded from the fNIRS measure.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Active tDCSActive tDCS will be applied using a wearable stimulator (LifTid) with a constant stimulation intensity of 1.2 mA for 20 minutes. The device has been designed for anodal stimulation targeting DLPFC using the F3 (anode) to F4 (cathode) montage. | Device | Active tDCS and yoga |
| Sham tDCSSham tDCS will be performed using the same device but without stimulation. During the yoga training, all participants will wear the device and a facilitator will turn on the stimulation for participants receiving a-tDCS-Y intervention, and pretend to turn on the stimulation for participants receiving s-tDCS-Y intervention after the first 10-minute section. | Device | Sham tDCS and yoga |
| YogaYoga will be based on the basic theory and research of the foundation of Hatha yoga. Participants will cultivate the learning of yoga through various kinds of activity, such as breathing control, body postures, and relaxation. The yoga is designed to create an overall effect on the body and mind through strength training and stretching with a mindful sensation. Each 1-hour intervention session contains reviewing the last week self-practice, breathing practice and warm-up (10 minutes), posture sequences (40 minutes), relaxation (5 minutes), reflection and feedback (5 minutes). Video clips will be provided through social media apps (i.e., WhatsApp, WeChat) to enable home-based practice at least twice weekly. A logbook will be distributed to the participants for their record of self-practice and will be reviewed weekly by the intervention facilitator. | Behavioural | Active tDCS and yoga, Sham tDCS and yoga |
Primary outcome
Verbal Fluency Test
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
A measure of executive function. Participants have to name as many animals as possible in 60 seconds. Higher scores indicate better executive functioning.
17 secondary outcomes
Logical Memory test
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Digit Span Test
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Positive and Negative Syndrome Scale (PANSS)
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Calgary Depression Scale
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Social and Occupational Functioning Assessment Scale (SOFAS)
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Role Functioning Scale (RFS)
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
The Short Form Health Survey (SF-36)
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
BMI
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Sit-and-Reach Test
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Standing Balance Test
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Digit Symbol Coding Test
Time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Letter Cancellation Test
Time frame: After the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Trail Making Test (TMT)
Time frame: After the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Changes of HbO and HbR in prefrontal regions during resting and cognitive task measured by fNIRS
Time frame: Baseline (T0), and after the 6-week interventions/waiting (T1)
Correlation of changes in HbO and HbR among prefrontal regions (connectivity)
Time frame: Baseline (T0), and after the 6-week interventions/waiting (T1)
Attendance of the interventions
Time frame: After the 6-week interventions/waiting (T1)
Home-based practice frequency and duration checklist
Time frame: After the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Cognitive Functioning
Enrolling by invitationPhase 4
Effects of Ciprofol on Perioperative Neurocognitive Function in Elderly Patients Undergoing Daytime Surgery
PND, POCD - Postoperative Cognitive Dysfunction
Recruiting
The Efficacy of an IADL-based Non-immersive Virtual Reality Training Program to Enhance ADL Performance and Cognitive Function for Persons at Risk of Dementia
Cognitive Enhancement, Subjective Cognitive Decline (SCD)
Recruiting
The Effects of Synchronous and Asynchronous Pilates Training Based on Telerehabilitation on Core Stabilization, Balance, Cognitive Functions, and Quality of Life in Individuals With Multiple Sclerosis: A Single-Blind Randomized Controlled Trial
Multiple Sclerosis
Recruiting
The Effects of Vestibulo-Ocular Reflex Exercises Added to Postural Stabilization Training in Chronic Ankle Instability
Ankle Sprains, Ankle Sprain Strain
Not yet recruiting
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease
Cerebral Small Vessel Disease, Vascular Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Active tDCS and Yoga in people with Cognitive Functioning and Psychosis, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Verbal Fluency Test (time frame: Baseline (T0), after the 6-week interventions/waiting (T1), and at the 3-month follow-up (T2)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026.